Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2740933763', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-4081', 'title': 'Abstract 4081: Superior SN-38 pharmacodynamic and tumor-accretion profiles of labetuzumab govitecan (IMMU-130) <i>versus</i> irinotecan in experimental human colonic cancer models', 'display_name': 'Abstract 4081: Superior SN-38 pharmacodynamic and tumor-accretion profiles of labetuzumab govitecan (IMMU-130) <i>versus</i> irinotecan in experimental human colonic cancer models', 'publication_year': 2017, 'publication_date': '2017-07-01', 'ids': {'openalex': 'https://openalex.org/W2740933763', 'doi': 'https://doi.org/10.1158/1538-7445.am2017-4081', 'mag': '2740933763'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-4081', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5018738015', 'display_name': 'Thomas M. Cardillo', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Thomas M. Cardillo', 'raw_affiliation_strings': ['Immunomedics, Inc., Morris Plains, NJ.'], 'affiliations': [{'raw_affiliation_string': 'Immunomedics, Inc., Morris Plains, NJ.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043569662', 'display_name': 'Robert M. Sharkey', 'orcid': 'https://orcid.org/0000-0003-1408-0905'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Robert M. Sharkey', 'raw_affiliation_strings': ['Immunomedics, Inc., Morris Plains, NJ.'], 'affiliations': [{'raw_affiliation_string': 'Immunomedics, Inc., Morris Plains, NJ.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044055404', 'display_name': 'Serengulam V. Govindan', 'orcid': 'https://orcid.org/0000-0003-4920-922X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Serengulam V. Govindan', 'raw_affiliation_strings': ['Immunomedics, Inc., Morris Plains, NJ.'], 'affiliations': [{'raw_affiliation_string': 'Immunomedics, Inc., Morris Plains, NJ.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021189242', 'display_name': 'Jennifer Donnel', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jennifer Donnel', 'raw_affiliation_strings': ['Immunomedics, Inc., Morris Plains, NJ.'], 'affiliations': [{'raw_affiliation_string': 'Immunomedics, Inc., Morris Plains, NJ.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039370600', 'display_name': 'Maria Zalath', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Maria Zalath', 'raw_affiliation_strings': ['Immunomedics, Inc., Morris Plains, NJ.'], 'affiliations': [{'raw_affiliation_string': 'Immunomedics, Inc., Morris Plains, NJ.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5003890903', 'display_name': 'David M. Goldenberg', 'orcid': 'https://orcid.org/0000-0001-5539-421X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'David M. Goldenberg', 'raw_affiliation_strings': ['Immunomedics, Inc., Morris Plains, NJ.'], 'affiliations': [{'raw_affiliation_string': 'Immunomedics, Inc., Morris Plains, NJ.', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.460252, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 63, 'max': 71}, 'biblio': {'volume': '77', 'issue': '13_Supplement', 'first_page': '4081', 'last_page': '4081'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9945, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9945, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9916, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.9845, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/sn-38', 'display_name': 'SN-38', 'score': 0.867244}, {'id': 'https://openalex.org/keywords/active-metabolite', 'display_name': 'Active metabolite', 'score': 0.61943376}, {'id': 'https://openalex.org/keywords/conjugate', 'display_name': 'Conjugate', 'score': 0.58998793}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.5148224}, {'id': 'https://openalex.org/keywords/camptothecin', 'display_name': 'Camptothecin', 'score': 0.46784863}], 'concepts': [{'id': 'https://openalex.org/C2780259306', 'wikidata': 'https://www.wikidata.org/wiki/Q412197', 'display_name': 'Irinotecan', 'level': 4, 'score': 0.95725083}, {'id': 'https://openalex.org/C2780508388', 'wikidata': 'https://www.wikidata.org/wiki/Q1750127', 'display_name': 'SN-38', 'level': 5, 'score': 0.867244}, {'id': 'https://openalex.org/C149151106', 'wikidata': 'https://www.wikidata.org/wiki/Q4677569', 'display_name': 'Active metabolite', 'level': 3, 'score': 0.61943376}, {'id': 'https://openalex.org/C197336794', 'wikidata': 'https://www.wikidata.org/wiki/Q5161150', 'display_name': 'Conjugate', 'level': 2, 'score': 0.58998793}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.5610492}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.5148224}, {'id': 'https://openalex.org/C179998833', 'wikidata': 'https://www.wikidata.org/wiki/Q381233', 'display_name': 'High-performance liquid chromatography', 'level': 2, 'score': 0.48270035}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.48122194}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4732345}, {'id': 'https://openalex.org/C2779682216', 'wikidata': 'https://www.wikidata.org/wiki/Q419964', 'display_name': 'Camptothecin', 'level': 2, 'score': 0.46784863}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.4674673}, {'id': 'https://openalex.org/C108215921', 'wikidata': 'https://www.wikidata.org/wiki/Q603741', 'display_name': 'Prodrug', 'level': 2, 'score': 0.41338974}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.38752916}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.34676033}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.29724044}, {'id': 'https://openalex.org/C43617362', 'wikidata': 'https://www.wikidata.org/wiki/Q170050', 'display_name': 'Chromatography', 'level': 1, 'score': 0.18389073}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.16311857}, {'id': 'https://openalex.org/C134306372', 'wikidata': 'https://www.wikidata.org/wiki/Q7754', 'display_name': 'Mathematical analysis', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C33923547', 'wikidata': 'https://www.wikidata.org/wiki/Q395', 'display_name': 'Mathematics', 'level': 0, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2017-4081', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.73, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4297498474', 'https://openalex.org/W4225948320', 'https://openalex.org/W3003305233', 'https://openalex.org/W2741955981', 'https://openalex.org/W2550413855', 'https://openalex.org/W2479920407', 'https://openalex.org/W2317760412', 'https://openalex.org/W2131063689', 'https://openalex.org/W2014550324', 'https://openalex.org/W1940591674'], 'abstract_inverted_index': {'Abstract': [0], 'BACKGROUND:': [1], 'IMMU-130': [2, 48, 84, 382], 'is': [3, 20, 332], 'an': [4], 'antibody-drug': [5], 'conjugate': [6], '(ADC)': [7], 'undergoing': [8], 'clinical': [9], 'investigation': [10], 'in': [11, 54, 141, 150, 196, 239, 274, 318, 360, 377, 403, 448], 'patients': [12, 378], 'with': [13, 70, 171, 285, 349, 410], 'metastatic': [14], 'colorectal': [15], 'cancer': [16, 452], '(ClinicalTrials.gov,': [17], 'NCT01605318).': [18], 'It': [19], 'composed': [21], 'of': [22, 40, 47, 83, 114, 210, 261, 278, 287, 353, 373, 397, 442, 457], 'a': [23, 29, 34, 207], 'humanized': [24], 'anti-CEACAM5': [25], 'IgG': [26, 160], 'conjugated': [27], 'via': [28], 'cleavable': [30], 'linker': [31], 'to': [32, 153, 175, 181, 338, 387, 391], 'SN-38,': [33, 124], 'topoisomerase-I': [35], 'inhibitor': [36], 'and': [37, 112, 117, 123, 126, 185, 296, 315, 320, 355, 363, 401, 416, 439], 'active': [38], 'form': [39], 'irinotecan.': [41, 304], 'We': [42], 'investigated': [43], 'the': [44, 142, 199, 211, 225, 236, 247, 262, 288, 307, 346, 361, 370, 458], 'potential': [45], 'advantage': [46, 331], 'versus': [49, 326, 446], 'irinotecan': [50, 71, 127, 447], 'for': [51, 251, 342, 461], 'SN-38': [52, 75, 87, 137, 156, 186, 193, 213, 230, 244, 254, 263, 271, 280, 290, 301, 311, 339, 354, 386, 400, 437], 'delivery': [53, 330], 'nude': [55], 'mice': [56], 'bearing': [57], 'CEA-expressing': [58], 'human': [59, 450], 'colonic': [60, 451], 'tumor': [61], 'xenografts': [62], '(LS174T': [63], 'or': [64, 80], 'GW-39).': [65], 'METHODS:': [66], 'Mice': [67], 'were': [68, 91, 103, 121, 129, 139, 188, 205, 297, 313, 357], 'injected': [69, 289, 341], '(~': [72], '900': [73], 'µg;': [74], 'equivalents': [76, 340], '=': [77], '~500': [78], 'µg)': [79], '1.0': [81], 'mg': [82], '(16': [85], 'µg': [86], 'equivalents).': [88], 'Irinotecan-treated': [89], 'animals': [90, 102], 'necropsied': [92], '5': [93, 179, 257], 'min,': [94, 258], '1,': [95, 106], '2,': [96], '6-8': [97], 'h': [98], 'post-injection,': [99], 'while': [100, 393], 'IMMU-130-treated': [101, 135, 267], 'evaluated': [104], 'at': [105, 256, 282, 293], '6,': [107], '24,': [108], '48-72': [109], 'h.': [110, 183, 228], 'Serum': [111], 'homogenates': [113], 'tumors,': [115, 250, 275, 322], 'liver,': [116], 'small': [118, 208, 364], 'intestinal': [119, 365], 'contents': [120], 'extracted,': [122], 'SN-38G,': [125], 'concentrations': [128, 138], 'determined': [130], 'by': [131, 163, 303], 'reversed-phase': [132], 'HPLC.': [133], 'For': [134], 'specimens,': [136], 'assessed': [140], 'extracted': [143], 'samples': [144, 152], '(Free': [145, 157], 'SN-38),': [146], 'as': [147, 149], 'well': [148], 'acid-hydrolyzed': [151], 'determine': [154], 'Total': [155, 212, 229, 279], '+': [158], 'bound).': [159], 'was': [161, 194, 218, 272], 'measured': [162], 'ELISA.': [164], 'RESULTS:': [165], 'Irinotecan': [166], 'cleared': [167], 'quickly': [168, 234], 'from': [169, 178, 246, 324], 'serum,': [170], '[SN-38]averaging': [172], '~900': [173], 'ng/mL': [174, 177], '200': [176], 'min': [180], '6': [182, 227, 283], 'SN-38G': [184, 217, 356, 402], 'levels': [187, 204, 231, 277, 312, 396], 'similar.': [189], 'With': [190], 'IMMU-130,': [191], 'Free': [192, 216, 270], 'detected': [195, 222, 273], 'serum': [197], 'over': [198], 'entire': [200], 'monitoring': [201], 'period,': [202], 'but': [203, 276], 'only': [206, 223], 'fraction': [209], '(~10%).': [214], 'Importantly,': [215], 'very': [219], 'low,': [220], 'being': [221], 'within': [224], 'first': [226], 'dropped': [232], 'more': [233, 385], 'than': [235, 300], 'IgG,': [237], 'confirming': [238], 'vitro': [240], 'studies': [241], 'showing': [242, 413], 'gradual': [243], 'release': [245], 'ADC.': [248], 'In': [249, 266], 'irinotecan-treated': [252], 'animals,': [253, 268], 'peaked': [255, 281], 'representing': [259], '≤0.2%/g': [260], 'equivalent': [264], 'given.': [265], 'no': [269], 'h,': [284], '~5%/g': [286], 'dose': [291], 'present': [292], 'that': [294], 'time,': [295], 'sustained': [298], 'longer': [299], 'delivered': [302], 'Area': [305], 'under': [306], 'curve': [308], 'analysis': [309], 'found': [310], '~10-': [314], '17-fold': [316], 'higher': [317], 'LS174T': [319], 'GW-39': [321], 'respectively,': [323], 'IMMU-130-dosed': [325], 'irinotecan-dosed': [327], 'animals.': [328], 'This': [329], 'amplified': [333], '&gt;': [334], '30-fold': [335], 'when': [336], 'normalized': [337], 'each': [343], 'product,': [344], 'illustrating': [345], 'improved': [347, 414], 'bioavailability': [348], 'IMMU-130-targeted': [350], 'SN-38.': [351], 'Levels': [352], 'appreciably': [358], 'lower': [359, 371], 'liver': [362], 'contents,': [366], 'which': [367], 'likely': [368], 'explains': [369], 'incidence': [372], 'severe': [374], 'diarrhea': [375], 'reported': [376], 'given': [379], 'IMMU-130.': [380], 'CONCLUSION:': [381], 'delivers': [383], '&gt;300-fold': [384], 'CEA-producing': [388], 'tumors': [389], 'compared': [390], 'irinotecan,': [392], 'also': [394], 'reducing': [395], 'potentially': [398], 'harmful': [399], 'normal': [404], 'tissues.': [405], 'These': [406], 'observations': [407], 'are': [408], 'consistent': [409], 'preclinical': [411], 'data': [412], 'efficacy': [415], 'safety.': [417], 'Citation': [418], 'Format:': [419], 'Thomas': [420], 'M.': [421, 424, 434], 'Cardillo,': [422], 'Robert': [423], 'Sharkey,': [425], 'Serengulam': [426], 'V.': [427], 'Govindan,': [428], 'Jennifer': [429], 'Donnel,': [430], 'Maria': [431], 'Zalath,': [432], 'David': [433], 'Goldenberg.': [435], 'Superior': [436], 'pharmacodynamic': [438], 'tumor-accretion': [440], 'profiles': [441], 'labetuzumab': [443], 'govitecan': [444], '(IMMU-130)': [445], 'experimental': [449], 'models': [453], '[abstract].': [454], 'In:': [455], 'Proceedings': [456], 'American': [459], 'Association': [460], 'Cancer': [462, 475], 'Research': [463], 'Annual': [464], 'Meeting': [465], '2017;': [466], '2017': [467], 'Apr': [468], '1-5;': [469], 'Washington,': [470], 'DC.': [471], 'Philadelphia': [472], '(PA):': [473], 'AACR;': [474], 'Res': [476], '2017;77(13': [477], 'Suppl):Abstract': [478], 'nr': [479], '4081.': [480], 'doi:10.1158/1538-7445.AM2017-4081': [481]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2740933763', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}], 'updated_date': '2024-12-24T11:19:21.860492', 'created_date': '2017-08-08'}